Hyperbaric oxygen therapy in the treatment of skin ulcers due to calcific uraemic arteriolopathy: Experience from an Australian hyperbaric unit

Diving and Hyperbaric Medicine

Volumn 38, Issue 3, 2008, Pages 139-144

  Edsell, Mark ^a,d   Bailey, Michael ^b   Joe, Keith ^c   Millar, Ian ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Calciphylaxis; Chronic wounds; Hyperbaric oxygen therapy; Outcome

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; OXYGEN; PHOSPHATE BINDING AGENT;

ADULT; AGE; ARTICLE; AUSTRALIA; CALCINOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEBRIDEMENT; DIALYSIS; FEMALE; HUMAN; HYPERBARIC OXYGEN; KIDNEY FAILURE; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; PARATHYROIDECTOMY; PREDICTION; SKIN TRANSPLANTATION; SKIN ULCER; TREATMENT OUTCOME; ULCER HEALING; UREMIA;

EID: 55049117501     PISSN: 18333516     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mathur RV, Shortland JR, El Nahas AM. Calciphylaxis. Postgrad Med J. 2001; 77: 557-61.
2. Podymow T, Wherrett C, Burns KD. Hyperbaric oxygen in the treatment of calciphylaxis: a case series. Nephrol Dial Transplant. 2001; 16: 2176-80.
3. Angelis M, Wong LL, Myers SA, Wong LM. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery. 1997; 122: 1083-9.
4. Selye H, editor. Generalities. In: Calciphylaxis. Chicago: University of Chicago Press; 1962.
5. Rees JK, Coles GA. Calciphylaxis in man. BMJ. 1969; 2: 670-2.
6. Coates T, Kirkland G, Dymock R, Murphy B, Brealey J, et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis. 1998, 32: 384-91.
7. Gallagher KA, Goldstein LJ, Thom SR, Velazquez OC. Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular. 2006; 14: 328-37.
8. Tibbles PM, Edelsberg JS. Hyperbaric oxygen therapy. N Engl J Med. 1996; 334: 1642-8.
9. Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A. Hyperbaric oxygen therapy for calcific uraemic arteriolopathy: A case series. J Nephrol. 2002; 15: 676-80.
10. Vassa N, Twardowski ZJ, Campbell J. Hyperbaric oxygen therapy in calciphylaxis-induced skin necrosis in a peritoneal dialysis patient. Am J Kidney Dis. 1994; 23: 878-81.
11. Dean SM, Werman H. Calciphylaxis: a favourable outcome with hyperbaric oxygen. Vasc Med. 1998; 3: 115-20.
12. Dwyer KM, Francis DMA, Hill PA, Murphy BF. Calcific uraemic arteriolopathy: local treatment and hyperbaric oxygen therapy. Nephrol Dial Transplant. 2002; 17: 1148-9.
13. Banky JP, Dowling JP, Miles C. Idiopathic calciphylaxis. Australas J Dermatol. 2002; 43: 190.
14. Hafner J, Keusch G, Wahl C, Burg G. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa. 1998; 27: 137-43.
15. Duffy A, Schurr M, Warner T, Chen H. Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol. 2006; 13: 96-102.
16. Hawkins GC, Bennett MH, Van der Hulst AE. The outcome of chronic wounds following hyperbaric oxygen therapy: a prospective cohort study - the first year interim report. Diving and Hyperbaric Medicine. 2006; 36: 94-8.
17. Hayden MR, Goldsmith D, Sowers JR, Khanna R. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol. 2008 Mar 28.
18. Raymond CB, Wazny LD. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm. 2008, 65: 1419-29.